BMJ 1996;312:491-494 (24 February)
Education and debate
Fortnightly Review: Paget's disease of bone: diagnosis and management
David Hosking,
consultant physician,a
Pierre J Meunier,
professor,b
Johann D Ringe,
professor,c
Jean-Yves Reginster,
professor,d
Carlo Gennari,
professor ea City Hospital, Hucknall Road, Nottingham NG5 1PB,
b Service de Rhumatologie et de Pathologie Osseuse, Hopital Edouard Herriot, Lyon, France,
c Klinikum Leverkusen, University of Cologne, Leverkusen, Germany,
d Centre Universitaire d'Investigation du Metabolisme Osseux et du Cartilage Articulaire, Liege, Belgium,
e Instituto de Patologia Medica, Policlinico "Le Scotto," Siena, Italy
Correspondence to: Dr Hosking.
|
Summary points
- Paget's disease is a localised monostotic or polyostotic progressive bone disease of uncertain origin (it may be caused by a slow viral infection)
- It is characterised by increased bone remodelling, leading to pain, fractures, and deformities with the risk of skeletal, articular, or neurological complications
- Radiography, scintigraphy, and bone biochemistry are useful tools in achieving a positive diagnosis
- The primary aim of treatment is to reduce pain and the risk of developing long term complications
- Potent antiresorptive drugs are now available which control the increased bone remodelling and have led to a dramatic improvement in treatment
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati
Twitter What's this?
Relevant Article
-
Disodium pamidronate has beneficial effect in Paget's disease of bone
- Kuntal Chakravarty, Peter Merry, and David G I Scott
BMJ 1996 312: 1476-1477.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Chakravarty, K., Merry, P., Scott, D. G I
(1996). Disodium pamidronate has beneficial effect in Paget's disease of bone. BMJ
312: 1476c-1477
[Full text]